Pfizer Inc (PFE)
25.42
-0.27
(-1.05%)
USD |
NYSE |
Apr 17, 16:00
25.50
+0.08
(+0.31%)
Pre-Market: 04:10
Pfizer Gross Profit Margin (Quarterly): 46.92% for Dec. 31, 2023
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 46.92% |
| September 30, 2023 | 29.95% |
| June 30, 2023 | 74.58% |
| March 31, 2023 | 73.27% |
| December 31, 2022 | 60.28% |
| September 30, 2022 | 73.22% |
| June 30, 2022 | 68.83% |
| March 31, 2022 | 61.09% |
| December 31, 2021 | 59.16% |
| September 30, 2021 | 58.68% |
| June 30, 2021 | 62.98% |
| March 31, 2021 | 71.36% |
| December 31, 2020 | 76.28% |
| September 30, 2020 | 80.47% |
| June 30, 2020 | 81.49% |
| March 31, 2020 | 80.76% |
| December 31, 2019 | 75.96% |
| September 30, 2019 | 79.48% |
| June 30, 2019 | 80.58% |
| March 31, 2019 | 81.45% |
| December 31, 2018 | 29.52% |
| September 30, 2018 | 79.74% |
| June 30, 2018 | 78.35% |
| March 31, 2018 | 80.14% |
| December 31, 2017 | 76.24% |
| Date | Value |
|---|---|
| September 30, 2017 | 78.40% |
| June 30, 2017 | 79.37% |
| March 31, 2017 | 80.69% |
| December 31, 2016 | 76.44% |
| September 30, 2016 | 76.35% |
| June 30, 2016 | 75.86% |
| March 31, 2016 | 78.08% |
| December 31, 2015 | 75.72% |
| September 30, 2015 | 81.64% |
| June 30, 2015 | 81.61% |
| March 31, 2015 | 83.08% |
| December 31, 2014 | 79.40% |
| September 30, 2014 | 80.84% |
| June 30, 2014 | 80.72% |
| March 31, 2014 | 81.99% |
| December 31, 2013 | 79.39% |
| September 30, 2013 | 81.91% |
| June 30, 2013 | 82.72% |
| March 31, 2013 | 81.76% |
| December 31, 2012 | 80.18% |
| September 30, 2012 | 82.17% |
| June 30, 2012 | 82.99% |
| March 31, 2012 | 81.56% |
| December 31, 2011 | 82.79% |
| September 30, 2011 | 79.48% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
29.95%
Minimum
Sep 2023
81.49%
Maximum
Jun 2020
68.18%
Average
73.22%
Median
Sep 2022
Gross Profit Margin (Quarterly) Benchmarks
| Amgen Inc | 62.03% |
| Gilead Sciences Inc | 70.62% |
| Johnson & Johnson | 68.23% |
| Viking Therapeutics Inc | -- |
| Moderna Inc | 66.97% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 2.19% |
| Return on Assets | 1.00% |
| Return on Invested Capital | 1.41% |
| Profit Margin (Quarterly) | -23.64% |
| Operating Margin (Quarterly) | -13.83% |
| Return on Net Operating Assets | 1.48% |